We are live on ! Find out more
XPH icon

State Street SPDR S&P Pharmaceuticals ETF

75 hedge funds and large institutions have $224M invested in State Street SPDR S&P Pharmaceuticals ETF in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 10 increasing their positions, 27 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 5

25% more funds holding

Funds holding: 6075 (+15)

10% more capital invested

Capital invested by funds: $204M → $224M (+$19.6M)

13.29% less ownership

Funds ownership: 110.25%96.97% (-13%)

63% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 27

Holders
75
Holders Change
+15
Holders Change %
+25%
% of All Funds
1.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
10
Reduced
27
Closed
5
Calls
$3.94M
Puts
Net Calls
+$3.94M
Net Calls Change
+$3.64M
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
76
Susquehanna International Group
Pennsylvania
-$1.3M -32,753 Closed
EW
77
Evoke Wealth
California
-$107K -3,000 Closed
QCIG
78
Quad-Cities Investment Group
Iowa
-$19K -530 Closed
AWM
79
Avior Wealth Management
Nebraska
-$3K -100 Closed
ONST
80
Old North State Trust
North Carolina
-$4K -100 Closed